Change in Management

BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: 11/12, Sector E Sanwer Road, Indore-452015 (M.P.) Tel. 0731-2723016; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2723017 Date: 11th August, 2026 To, To, The Secretary (DCS/Compliance), The Secretary (Listing/Compliance), Corporate Relationship Department, Corporate Relationship Department, BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai-400001 Complex, Mumbai – 400051 Sub: Continuous Disclosure of material events or information under sub-clause 7 of Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015 Reference: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Script Code: 524396; NSE Symbol: BIOFILCHEM; ISIN: INE829A01014) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026, regarding continuous disclosure requirements for listed entities, we hereby submit the disclosure as required under Sub-Para 7 of Para A of Part A of Schedule III of the Listing Regulations in respect of the continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non- Executive Independent Director of the Company, notwithstanding his attaining the age of 75 (seventy-five) years. The detailed disclosure and brief profile of Mr. Ashok Kumar Ramawat are enclosed herewith as Annexure-A. The aforesaid continuation of directorship has been approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee and is subject to approval of the shareholders by way of Special Resolution at the ensuing 41st Annual General Meeting of the Company, pursuant to Regulation 17(1A) of the Listing Regulations. Further, the aforesaid continuous disclosure is also being submitted in the prescribed XBRL format through the filing utility provided by the Stock Exchanges, along with the disclosure in PDF format, within the prescribed time limit. The above information will also be made available on the website of the Company at www.biofilgroup.net. The meeting of the Board of Directors commenced at 04:30 P.M. and concluded at 05:30 P.M. You are requested to kindly take the above information on record. Thanking You, Yours Faithfully, FOR BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739 CONTINUOUS DISCLOSURE UNDER SUB-CLAUSE 7 OF PARA A OF PART A OF SCHEDULE III PURSUANT TO REGULATION 30 OF THE SEBI (LODR) REGULATION, 2015 Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non- Executive Independent Director of the Company notwithstanding attaining the age of 75 (seventy-five) years Sr. No. Particulars Disclosure 01 Reason for change viz. Continuation of directorship of Mr. Ashok Kumar appointment, re-appointment, Ramawat (DIN: 08818263) as a Non-Executive resignation, removal, death or Independent Director of the Company otherwise notwithstanding attaining the age of 75 (seventy- five) years, pursuant to Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 02 Date of appointment/re- Mr. Ashok Kumar Ramawat was originally appointment/cessation and appointed as a Non-Executive Independent term of appointment/re- Director of the Company with effect from 25th appointment August, 2020. The Board has approved his continuation as a Non-Executive Independent Director notwithstanding his attaining the age of 75 years, subject to approval of the shareholders by way of Special Resolution at the ensuing 41st Annual General Meeting of the Company. 03 Brief Profile Mr. Ashok Kumar Ramawat has completed Bachelors Degree in Science. He possesses 46 years of post-qualification experience and a good exposure in Pharmaceuticals Industry. 04 Disclosure of relationships Mr. Ashok Kumar Ramawat is not related to any of between Directors the Directors or Key Managerial Personnel of the Company. In compliance to the Circular No. LIST/COMP/14/2018-19 dated June 20, 2018 issued by BSE and Circular No. NSE/CML/2018/24 dated June 20, 2018 issued by NSE, we confirm that Mr. Ashok Kumar Ramawat (DIN: 08818263) is not debarred from holding the office of Director by virtue of any order of SEBI or any other regulatory/statutory authority. Thanking You, Yours Faithfully, FOR BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739